In terms of diabetes compensation, repeated HBOT throughout the year reduces insulin consumption, recovers residual insulin secretion, and suppresses the release of contra-insular hormones such as glucagon, somatotropic hormone, and hydrocortisone. This evidence concerns the gene INS and diabetes mellitus.